Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, María Trojano, Elio Prestipino et al.|Brain|2020Cited by 90
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological SocietyG. Tedeschi, Angelo Ghezzi, L. M. E. Grimaldi et al.|Neurological Sciences|2011Cited by 19
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosisViola Baione, Antonella Conte, Daniele Belvisi et al.|Multiple Sclerosis and Related Disorders|2019Cited by 19